MKRN2 and drug-induced dyskinesia: According to our results, lnc‐MKRN2‐42:1 expression levels were positively correlated with the severity of dyskinesia and dysarthria but were not correlated with other clinical symptoms, so only the correlation analysis for UPDRS III is presented here.